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Background: Population colorectal cancer screening programmes have been introduced to reduce cancer-specific mortality
through the detection of early-stage disease. The present study aimed to examine the impact of screening introduction in the
West of Scotland.
Methods: Data on all patients with a diagnosis of colorectal cancer between January 2003 and December 2012 were extracted
from a prospectively maintained regional audit database. Changes in mode, site and stage of presentation before, during and
after screening introduction were examined.
Results: In a population of 2.4 million, over a 10-year period, 14 487 incident cases of colorectal cancer were noted. Of these, 7827
(54%) were males and 7727 (53%) were socioeconomically deprived. In the postscreening era, 18% were diagnosed via the
screening programme. There was a reduction in both emergency presentation (20% prescreening vs 13% postscreening, Pp0.001)
and the proportion of rectal cancers (34% prescreening vs 31% pos-screening, Pp0.001) over the timeframe. Within non-
metastatic disease, an increase in the proportion of stage I tumours at diagnosis was noted (17% prescreening vs 28%
postscreening, Pp0.001).
Conclusions: Within non-metastatic disease, a shift towards earlier stage at diagnosis has accompanied the introduction of a
national screening programme. Such a change should lead to improved outcomes in patients with colorectal cancer.
Several large randomised control trials examining guaiac-based
faecal occult blood test (gFOBt) colorectal cancer screening
programmes have shown a reduction in cancer-specific mortality
through the detection of early-stage disease (Mandel et al, 1993;
Kronborg et al, 1996; Scholefield et al, 2002). Therefore,
national bowel screening programmes have been introduced
across the United Kingdom over the past 10 years. However,
it is important to consider screening within the context of the
whole population that is being served by the screening programme.
For example, the current Scottish Bowel Screening Programme
(SBoSP) is targeted only at those aged between 50 and 74 years,
with few over the age of 74 years opting for further testing.
In addition, there is limited uptake, sensitivity and specificity of the
testing algorithms in use. Therefore, clearly, not all tumours will be
screen detected, and it is unclear what the overall impact on the
population will be.
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Indeed, a previous single centre study from Scotland has
suggested that screen-detected tumours may account for just 17%
of all tumours diagnosed within a population invited to screening
(Roxburgh et al, 2013). Additionally, it has been noted that despite
the programme detecting an increased number of early-stage
tumours, it may not lead to an overall stage shift to earlier disease
across the population (Roxburgh et al, 2013).
The aim of the present study was to examine the impact that
screening has had on the mode, site and stage of presentation of
colorectal cancer in the West of Scotland over the past decade.
The aim was to achieve this by using population statistics from the
West of Scotland Managed Clinical Network (MCN) to compare
cohorts before, during and after the introduction of the SBoSP.
PATIENTS AND METHODS
The MCN covers four Health Boards (Ayrshire and Arran, Forth
Valley, Greater Glasgow and Clyde and Lanarkshire) comprising
16 different hospitals and covering a population of over 2.4 million,
just under half of the population of Scotland (Table 1). It was
created in 2000 with the aim of improving outcomes in colorectal
cancer. All patients discussed at a local hospital multidisciplinary
team (MDT) with a diagnosis of colorectal cancer are included,
with the clinicopathological data prospectively recorded. Details
including age, sex, socioeconomic deprivation status, mode
of presentation and tumour site and stage are routinely stored.
For the present study, data were extracted for a period from 1st
January 2003 to 31st December 2012.
The mode of presentation was defined as emergency if the
patient underwent management involving a hospital admission
that was unplanned. This included, but was not limited to,
significant rectal bleeding, colonic obstruction and perforation.
Other routes were defined as elective including screen detected,
which was introduced as a data point from 2007 onwards.
Tumour site was classified according to anatomical site as per
the International Classification of Disease version 10 (ICD-10).
Lesions up to, but not including, the splenic flexure were classified
as right sided (C18.0–C18.4), those from splenic flexure up to, but
not including, the retosigmoid junction were defined as left sided
(CC18.5–C18.7) and tumours of the rectosigmoid junction
and rectum were classed as rectal (C19 and C20). Tumour stage
was defined according to the standard TNM (version 5)
classification (Sobin and Fleming, 1997) based on histological
resection of specimens and, in those who did not under go
resection, on preoperative imaging modalities. Polyp cancers,
which underwent endoscopic excision only, were classified as stage
I disease. Intent of procedure was collated at the time of resection
as either curative or palliative by the surgical team responsible for
each individual patient.
Socioeconomic deprivation status was calculated from the
Scottish Index of Multiple Deprivation, which is an index of
relative deprivation (Scottish Government, 2009). Quintiles of
deprivation were used to assign individuals to a relative deprivation
category based on their postcode at their time of diagnosis, with the
first quintile representing the most deprived and the fifth quintile,
the least deprived. The most current version of SIMD was used at
the time of data collection (i.e., SIMD 2004 for patients in 2003 to
2005, SIMD 2006 for patients in 2006, 2007 and 2008 .and so on).
The SBoSP is a biennial gFOBt/faecal immunochemical test
(FIT)-based screening programme for all individuals aged 50–74
years. Details regarding the current screening algorithm have been
published previously (Fraser et al, 2012). Briefly, all individuals
aged 50–74 years are sent a preinvitation letter and then a gFOBt,
and later referred for colonoscopy if this is returned and is strongly
positive (X5 of 6 windows positive). In the case of a weakly
positive gFOBt (1–4 of 6 windows positive), spoiled or untestable
kit, a confirmatory FIT is sent. Individuals then proceed to
colonoscopy, following preassessment by a bowel screening
preassessment nurse. Screening was introduced across the four
Health Boards at staged intervals (Table 1); therefore, the data were
separated into five distinct time frames: 2003–2004 early pre-
screening (EPrS), 2005–2006 late prescreening, 2007–2008 early
introduction of screening, where the minority of the population
were invited, 2009–2010 late introduction of screening, where
the majority of the population were invited and 2011 to 2012
postintroduction of screening (PoS), where screening had been
introduced across all four boards. This allowed for assessment not
only of the impact of screening but also of the temporal changes in
disease presentation and management across the area over the
decade.
Permission for the study was granted by the Caldicott guardian
for the data and all data were stored and analysed in an
anonymised manner
Statistical analyses. The w2 test for linear trend was used to test
associations between variables and calendar time. A P-valuep0.05
was considered statistically significant. Statistical analysis was
performed using the SPSS software (SPSS Inc., Chicago, IL, USA)
RESULTS
From 1st January 2003 to 31st December 2012, inclusive, there
were 14 487 incident cases of colorectal cancer. There were 7827
(54%) males, 8142 (56%) patients were between 50 and 74 years
old and 7727 (53%) patients were in the two most deprived
quintiles of deprivation. Overall, 2163 (15%) patients presented to
surgery as an emergency (Table 2).
On examining patient demographics over the decade of analysis,
there were no changes seen in the age and sex of patients at
diagnosis; however, there was a weak trend for those in PoS to be
more deprived in later years (P¼ 0.057). There was a significant
reduction in the proportion of patients presenting to surgery as an
Table 1. Population of NHS Health Boards across Scotland,
date of screening introduction and uptake of test
NHS Health
Board
Population
(est. 2009)
Screening
introduction
Screening
uptake (%)a
Grampian 559 210 June 2007 61
Fife 361 410 June 2007 56
Tayside 404 390 June 2007 59
Ayshire and
Arran
372380 September
2007
55
Orkney 20 940 October 2007 63
Forth Valley 294140 December 2007 55
Lothian 816 640 May 2008 54
Western Isles 27 420 July 2008 57
Dumfries and
Galloway
151 160 December 2008 58
Greater Glasgow
and Clyde
1199830 April 2009 53
Lanarkshire 569800 August 2009 48
Shetland 22 790 October 2009 64
Borders 113 380 November 2009 60
Highland 318 200 December 2009 61
Abbreviation: NHS¼National Health Service.
aDerived from invitations between 1st November 2010 and 31st October 2012 (Information
Services Division Scotland (ISD), 2013).
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emergency over the timeframe from 20% EPrS to 13% PoS
(Pp0.001) (Table 2).
On examining tumour characteristics, there was a reduction in
the proportion of rectal cancers diagnosed over the timeframe from
34% EPrS to 31% PoS (P¼ 0.001). Comparing procedure intent,
excluding those who did not undergo a procedure, more patients
underwent a procedure with a curative intent in later years (76%
EPrS vs 84% PoS, Pp0.001) (Table 2). Overall, 3379 (23%) patients
had incomplete TNM staging information and 708 (5%) patients
had evidence of distant metastatic disease. These were subsequently
excluded from analysis and stage I–III disease was examined
independently. Over the timeframe, there was a shift among
those without distant metastases towards a higher proportion of
stage I cancers in later years (17% EPrS vs 28% PoS, Pp0.001)
(Table 3).
Patients with colorectal cancer diagnosed in the PoS timeframe
were further examined to compare screen-detected and non-
screen-detected disease (Table 4). Patients with screen-detected
disease were more likely to be younger (Pp0.001), male
(Pp0.001), less deprived (P¼ 0.002) and present electively
(Pp0.001). In addition screen-detected tumours were more likely
to be distal (Pp0.001), of an earlier stage (Pp0.001) and managed
with a curative intent (Pp0.001).
DISCUSSION
The results of the present study provide an overview of the changes
in mode, site and stage of colorectal cancer presentation in a single
geographical area over the past decade, accompanying the
introduction of a national screening programme. The results show
a reduction in emergency presentation, a reduction in the
proportion of rectal cancers and a shift among those without
distant metastases to earlier stage at diagnosis. Furthermore, an
overall increase in the proportion of patients managed with a
curative intent has been identified.
Examining the impact of screening on overall TNM stage at
presentation using population-based data sets can be problematic.
This is because of high number of patients with incomplete staging
information and limited information on those with metastatic
disease. For example, in a recent population study examining
tumours diagnosed within and without the English Bowel Cancer
Screening Programme, 25% of cases were unstaged (Morris et al,
2012), similar to the present study. In addition, patients who do
not have complete staging information are more likely to die closer
to their time of diagnosis, implying the presence of more advanced
disease (Downing et al, 2013).
Table 2. Temporal trends in colorectal cancer presentation with the introduction of screening
All patients Pre-screening Screening introduction Postscreening
Early Late Early Late
2003–2004 2005–2006 2007–2008 2009–2010 2011–2012
n (14 487) % n (2380) % n (2384) % n (3098) % n (3282) % n (3343) % P-value
Age (years)
p50 751 5 129 5 129 5 172 6 139 4 182 5
50–74 8142 56 1250 53 1368 57 1702 55 1897 58 1925 58
X75 5299 37 851 35 793 33 1202 39 1224 37 1229 37 0.584
Unknown 295 2 150 6 94 4 22 1 23 1 6 0
Sex
Female 6364 44 1017 42 1054 44 1384 45 1416 43 1493 45
Male 7827 54 1213 51 1236 52 1692 55 1843 56 1843 55 0.169
Unknown 296 2 150 6 94 4 22 1 23 1 7 0
Deprivation category
1 (most deprived) 4329 30 667 28 706 30 935 30 978 30 1043 31
2 3398 23 545 23 555 23 732 24 776 24 790 24
3 2370 16 364 15 380 16 529 17 557 17 540 16
4 1921 13 307 13 300 13 406 13 433 13 475 14
5 (least deprived) 2072 14 247 16 349 15 474 15 514 16 488 15 0.057
Unknown 297 2 150 6 94 4 22 1 24 1 7 0
Presentation to surgery
Emergency 2163 15 480 20 431 18 414 13 420 13 418 13
Elective
Symptomatic 8948 62 1849 78 1868 78 1910 62 1729 53 1592 47
Screen detecteda 1200 8 — — — — 107 3 486 15 607 18 p0.001b
Did not undergo procedure 2056 14 30 1 56 2 624 20 642 20 704 21
Unknown 115 1 21 5 29 3 43 1 5 0 22 1
Site of tumour
Right colon 4857 34 753 32 811 34 1048 34 1099 34 1146 34
Left colon 4827 33 790 33 736 31 997 32 1165 35 1139 34
Rectum 4647 32 825 34 818 34 996 32 983 30 1025 31 0.001
Multiple/unknown 156 1 12 1 19 1 57 2 35 1 33 1
Management Intent
Curative intent 9980 68 1797 76 1744 73 1972 64 2238 68 2229 67
Palliative procedure 1877 13 440 18 389 16 337 11 334 10 377 11 p0.001c
Did not undergo procedure 2056 14 30 1 56 2 624 20 642 20 704 21
Unknown/other 574 4 113 5 195 8 165 5 68 2 33 1
aRecorded from 2007 onwards.
bEmergency vs all elective (including screen detected).
cCurative vs palliative resection.
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The MCN has been created to improve outcome in colorectal
cancer through delivery of high-quality care with a focus on
surgical outcomes. Data are collated following local MDT
discussion; therefore, information on patients with metastatic
disease who are managed palliatively is poorly captured. It is
recognised that this limitation of the data set is particularly true in
the early cohorts. For example, only 1% of patients in the EPrS
timeframe did not undergo a procedure compared with 20% of
patients in PoS timeframe. Furthermore, examining stage IV
disease across the timeframe actually showed an increase from 3%
(EPrS) to 9% (PoS) with a concurrent rise in unstaged disease from
13% (EPrS) to 25% (PoS) (data not presented). However, this
clearly identifies a failure in capture of metastatic or incompletely
staged patients of the MCN data set.
Therefore, to maintain data quality when examining stage, the
present study chose to focus only on those without distant
metastases. When this was considered separately, a clear trend
towards larger proportions of node-negative and stage I disease
following screening introduction was seen. It has been reported
that tumours detected through the screening pathway are of an
earlier stage compared with non-screen detected and the present
study supports this finding (Morris et al, 2012; Roxburgh et al,
2013). In addition, despite only accounting for 18% of all tumours
diagnosed, an overall impact on the population has been noted.
Such a change may well be associated not only with the test itself
but also with an overall improvement in the knowledge and
attitudes of the population with the widespread publication of
screening information. However, a degree of caution should be
excercised in interpreting this stage shift among those without
distant metastases, as it has been shown that the proportion of
stage I disease may well reduce with successive screening rounds
(Steele et al, 2009). Hence, further work examining the impact on
stage at a population level as subsequent rounds of screening occur
is required for clarification.
Emergency presentation has long been associated with both
poorer short-term (Anderson et al, 1992; McArdle and Hole, 2004)
and long-term outcomes (McMillan et al, 2010; Gunnarsson et al,
2011). This disparity has been shown to exist even when node-
negative disease is examined independently (Oliphant et al, 2014).
The reason for this poorer outcome appears multifactorial
incorporating elements such as tumour characteristics (Wong
et al, 2008), preoperative patient morbidity (Skala et al, 2009), use
of a specialist surgeon (Biondo et al, 2010) and the presence of an
elevated host preoperative systemic inflammatory response
(Crozier et al, 2009). There is evidence from the Nottingham
gFOBt screening trial that emergency presentation is reduced in a
population undergoing screening (Scholefield et al, 1998). In
addition, the Coventry arm of the population pilot study reported
similar findings, with emergency admissions from colorectal cancer
reducing from 29% in 1999 to 16% in 2004, with a concomitant
improvement in 30-day mortality, following screening
introduction (Goodyear et al, 2008). Interestingly, the present
study showed a reduction in the proportion of emergency
presentation before the introduction of screening; however, little
change occurs during its rollout and widespread adoption. It
therefore questions the impact that screening itself has had on
overall emergency presentation in our geographical area. This is in
keeping with a recently published cohort study, which has shown
that emergency admissions are reduced when comparing partici-
pants and non-participants in screening; however, they remain
similar comparing cohorts invited and not invited to screening
(Libby et al, 2014). Therefore, it appears that it is participation and
not invitation that is the key determinant in reducing emergency
admissions.
In the present study, only 18% of all patients in the PoS cohort
presented through the screening programme. This is on the
background of an overall uptake of screening in our geographical
region of 52%, with lower uptake in the most deprived cohorts
(Mansouri et al, 2013). Higher rates of emergency presentation are
associated with socioeconomic deprivation and elderly age
(Gunnarsson et al, 2013). However, such deprived patients are
less likely to choose to participate in screening (Steele et al, 2010;
von Wagner et al, 2011) and patients over the age of 74 years are
currently not routinely invited to screening. Moreover, it has
previously been shown that those patients who are socioeconomi-
cally deprived have a worse outcome following a diagnosis of
colorectal cancer (Kelsall et al, 2009; Oliphant et al, 2013). Hence,
the current screening programme may underserve the very people
who do worse. Efforts to improve uptake of the programme should
therefore be made to target such subgroups. One of the concerns
raised regarding screening is that it may widen the gap in outcomes
that has been created by socioeconomic deprivation and this may
be associated with its effect on the rate of emergency presentation.
Strengths and limitations. The strengths of the present study are
its size and the prospectively collected core data set including data
on emergency presentation. It is recognised that there are issues
with utilising population-based databases such as missing data.
Nevertheless, such prospective data sets provide an opportunity to
examine overall trends. Furthermore, there are additional tumour
and host variables that determine outcome independent of TNM
stage, which would be of interest to explore; however, these were
not collected prospectively over the time period. This is particularly
relevant for stage II disease, where outcome can be varied
(Roxburgh et al, 2014; Park et al, 2015). Further work with mature
follow-up and detailed tumour and host information is required to
assess the impact on outcome in particular in stage II disease.
A further limitation is utilising data over a decade, where staging
modalities may have altered. For example, changes in the
sensitivity of CT in detecting metastatic disease or changes in the
approach to the pathological processing of specimens may have led
to a comparative understaging of those in the earlier cohorts (i.e., a
Table 3. Temporal trends in TNM stage of colorectal cancer at presentation with the introduction of screening (non-metastatic
disease only)
Prescreening Screening introduction Postscreening
Early Late Early Late
All patients 2003–2004 2005–2006 2007–2008 2009–2010 2011–2012
n (10400) % n (1999) % n (1992) % n (2072) % n (2118) % n (2219) % P-value
Stage
I 2134 17 348 17 329 17 367 18 461 22 629 28
II 4124 40 791 40 803 40 884 42 834 40 812 37
III 4142 43 860 43 860 43 821 40 823 39 778 35 p0.001
Abbreviation: TNM¼ tumour node metastasis.
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more attentive approach to lymph node examination in later
years). However, such bias is difficult to avoid when examining
historical data. Finally, our definition of emergency presentation
includes those admitted with acute bleeding. Recently, it has been
reported that those patients with colorectal cancer who present
with GI bleeding have a better outcome than others, and as such
grouping these along with colonic perforation and obstruction is
suboptimal (Alexiusdottir et al, 2013). Nevertheless, this was the
definition of an emergency as coded prospectively in the data set
and therefore precluded more detailed analysis.
In conclusion, examining population data from the West of
Scotland over the past decade has identified that the SBoSP now
accounts for 18% of all tumours encountered in clinical practice.
Over the past decade, accompanying the introduction of screening,
there has been a reduction in the rate of emergency presentation, a
rise in the proportion of operative procedures performed with a
curative intent and, in patients with no evidence of distant
metastases, a shift towards an increased number of earlier stage
tumours. These changes are likely to improve outcomes overall in
the West of Scotland for patients presenting with colorectal cancer;
however, there is a need for high-quality follow-up to establish this.
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